Summary The pharmaceutical industry is transitioning away from animal tests, per the recent FDA Roadmap. Scientists’ need for drug development insights without animals has spurred greater interest in New Approach Methodologies (NAMs), such as in silico ... Read More
Track: Accelerating rare disease therapeutics via adoption of human biology-based non-clinical drug development in global north and global south countries Human Health - Replacement Session Chair Janette Turner - Humane World for Animals Session Speakers Abstract 553 Utilization ... Read More
ACS Fall 2025 Aug. 17-21 Speaker James Hickman, PhD, Hesperos Co-Founder and Chief Scientist Aug. 19, 11:20 AM Human-on-a-chip systems for determining therapeutic index in pre-clinical drug discovery About ACS Fall 2025: Organized by the American ... Read More
